Japan Falls Behind In Biotech Start-Ups As Venture Capital Lags
This article was originally published in PharmAsia News
Executive Summary
Japan's biotechnology industry is hampered by a lack of investment capital for a segment of the drug-making industry that is flourishing in other countries.